HURA
TuHURA Biosciences Inc.

15,530
Mkt Cap
$32.49M
Volume
286,115.00
52W High
$5.03
52W Low
$0.5264
PE Ratio
-0.82
HURA Fundamentals
Price
$0.5351
Prev Close
$0.561
Open
$0.559
50D MA
$1.09
Beta
0.50
Avg. Volume
606,595.73
EPS (Annual)
-$1.21
P/B
1.66
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone
TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone TuHURA Biosciences Announces its...
PR Newswire·2mo ago
News Placeholder
More News
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen cut TuHURA Biosciences from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·2mo ago
News Placeholder
TuHURA Biosciences Provides Corporate Update Following Recent Financing
TuHURA Biosciences Provides Corporate Update Following Recent Financing TuHURA Biosciences Provides Corporate Update Following Recent Financing PR Newswire TAMPA, Fla., Dec. 11, 2025 Company's lead...
PR Newswire·2mo ago
News Placeholder
TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering
TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering PR Newswire TAMPA, Fla., Dec. 9, 2025 TAMPA...
PR Newswire·2mo ago
News Placeholder
TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and Exposition
TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and...
PR Newswire·2mo ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of TuHURA Biosciences from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·2mo ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen cut TuHURA Biosciences from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·2mo ago
News Placeholder
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of "Buy" from Brokerages
TuHURA Biosciences, Inc. (NASDAQ:HURA - Get Free Report) has earned an average rating of "Buy" from the six analysts that are covering the company, Marketbeat reports. One investment analyst has...
MarketBeat·2mo ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Releases Earnings Results, Beats Estimates By $0.01 EPS
TuHURA Biosciences (NASDAQ:HURA - Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of...
MarketBeat·3mo ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Price Target Cut to $8.00 by Analysts at Maxim Group
Maxim Group decreased their price target on TuHURA Biosciences from $15.00 to $8.00 and set a "buy" rating for the company in a research note on Friday...
MarketBeat·3mo ago
<
1
2
...
>

Latest HURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.